Minocycline to Treat Amyotrophic Lateral Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

January 31, 2007

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

minocycline

Trial Locations (30)

10032

Columbia Unversity, Eleanor and Lou Gehrig MDA/ALS Center, New York

19104

University of Pennsylvania, Philadelphia

Unknown

Mayo Clinic, Scottsdale

University of California, Irvine, Irvine

University of California Department of Neurology, Los Angeles

California Pacific Medical Center, San Francisco

Univ. of Colorado Health Sciences Center, Denver

Mayo Clinic, Jacksonville

University of Illinois, Chicago

Indiana University School of Medicine, Indianapolis

University of Iowa, Iowa City

University of Kansas Medical Center, Kansas City

University of Kentucky, Lexington

Hennepin County Med Center, Minneapolis

University of Minnesota, Minneapolis

Washington University, St Louis

UMDNJ/Robert Wood Johnson Medical Center, New Brunswick

University of New Mexico, Albuquerque

Carolinas Medical Center, Charlotte

Duke University, Durham

Wake Forest University, Winston-Salem

Metro Health Clinic, Cleveland

Oregon Health & Science University, Portland

Drexel University College of Medicine, Hahnemann Campus, Philadelphia

University of Texas Southwestern, Dallas

Methodist Hospital, Houston

University of Texas Health Sciences Center, San Antonio

University of Utah, Salt Lake City

University of Vermont, Burlington

Virginia Mason Medical Center, Seattle

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00047723 - Minocycline to Treat Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter